Publicação: Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents
dc.contributor.author | Carmo, Arturene M. L. | |
dc.contributor.author | Silva, Flavia M. C. | |
dc.contributor.author | Machado, Patricia A. | |
dc.contributor.author | Fontes, Ana P. S. | |
dc.contributor.author | Pavan, Fernando Rogério [UNESP] | |
dc.contributor.author | Leite, Clarice Queico Fujimura [UNESP] | |
dc.contributor.author | Leite, Sergio R. de A. [UNESP] | |
dc.contributor.author | Coimbra, Elaine S. | |
dc.contributor.author | Da Silva, Adilson D. | |
dc.contributor.institution | Universidade Federal de Juiz de Fora (UFJF) | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-20T13:24:16Z | |
dc.date.available | 2014-05-20T13:24:16Z | |
dc.date.issued | 2011-06-01 | |
dc.description.abstract | A series of 4-amino-7-chloroquinoline derivatives were synthesized by the reaction of 4,7-dichloroquinoline with the corresponding diamine and then with propargyl bromide. In addition, platinum(II) complexes were obtained by reacting some of the organic derivatives with K(2)PtCl(4). Several of the synthesized compounds displayed antituberculosis activities. Compound 3 was 47.5 times more active than amphotericin B against Leishmania chagasi (IC(50) = 0.04 mu g/mL). Compounds 5, 6, 7, 9, 10, 11 and 13 presented promising results against Mycobacterium tuberculosis, with MIC values ranging from 12.5 to 15.6 mu g/mL, comparable to the "first and second line'' drugs used to treat tuberculosis. (C) 2011 Elsevier Masson SAS. All rights reserved. | en |
dc.description.affiliation | Univ Fed Juiz Fora, Dept Quim, ICE, BR-36036900 Juiz de Fora, MG, Brazil | |
dc.description.affiliation | Univ Fed Juiz Fora, Dept Parasitol Microbiol & Imunol, ICB, BR-36036900 Juiz de Fora, MG, Brazil | |
dc.description.affiliation | Univ Estadual Paulista, Fac Ciencias Farmaceut, BR-14801902 Araraquara, SP, Brazil | |
dc.description.affiliation | Univ Estadual Paulista, Inst Quim, BR-14801902 Araraquara, SP, Brazil | |
dc.description.affiliationUnesp | Univ Estadual Paulista, Fac Ciencias Farmaceut, BR-14801902 Araraquara, SP, Brazil | |
dc.description.affiliationUnesp | Univ Estadual Paulista, Inst Quim, BR-14801902 Araraquara, SP, Brazil | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorship | BIC/UFJF | |
dc.description.sponsorshipId | FAPESP: 08/10390-2 | |
dc.description.sponsorshipId | FAPESP: 09/06499-1 | |
dc.format.extent | 204-209 | |
dc.identifier | http://dx.doi.org/10.1016/j.biopha.2011.01.003 | |
dc.identifier.citation | Biomedicine & Pharmacotherapy. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 65, n. 3, p. 204-209, 2011. | |
dc.identifier.doi | 10.1016/j.biopha.2011.01.003 | |
dc.identifier.issn | 0753-3322 | |
dc.identifier.lattes | 2114570774349859 | |
dc.identifier.uri | http://hdl.handle.net/11449/7484 | |
dc.identifier.wos | WOS:000296960200011 | |
dc.language.iso | eng | |
dc.publisher | Elsevier France-editions Scientifiques Medicales Elsevier | |
dc.relation.ispartof | Biomedicine & Pharmacotherapy | |
dc.relation.ispartofjcr | 3.457 | |
dc.relation.ispartofsjr | 0,951 | |
dc.rights.accessRights | Acesso restrito | pt |
dc.source | Web of Science | |
dc.subject | 4-aminoquinoline analogues | en |
dc.subject | Platinum(II) complexes | en |
dc.subject | Antileishmanial | en |
dc.subject | Antitubercular | en |
dc.subject | Leishmania | en |
dc.subject | Mycobacterium tuberculosis | en |
dc.title | Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents | en |
dc.type | Artigo | pt |
dcterms.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dcterms.rightsHolder | Elsevier France-editions Scientifiques Medicales Elsevier | |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | 5004bcab-94af-4939-b980-091ae9d0a19e | |
relation.isDepartmentOfPublication.latestForDiscovery | 5004bcab-94af-4939-b980-091ae9d0a19e | |
relation.isOrgUnitOfPublication | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
relation.isOrgUnitOfPublication.latestForDiscovery | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
unesp.author.lattes | 2114570774349859 | |
unesp.author.orcid | 0000-0002-6969-3963[5] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquara | pt |
unesp.department | Ciências Biológicas - FCF | pt |
Arquivos
Licença do Pacote
1 - 2 de 2
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: